Millennium Management LLC Trims Stake in Viewray Inc (VRAY)

Millennium Management LLC decreased its holdings in shares of Viewray Inc (NASDAQ:VRAY) by 9.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,472,483 shares of the company’s stock after selling 359,642 shares during the period. Millennium Management LLC owned approximately 3.63% of Viewray worth $21,078,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of VRAY. Pearl River Capital LLC bought a new stake in shares of Viewray in the fourth quarter worth about $28,000. Hanson McClain Inc. bought a new stake in shares of Viewray in the fourth quarter worth about $29,000. NumerixS Investment Technologies Inc grew its stake in shares of Viewray by 90.6% in the fourth quarter. NumerixS Investment Technologies Inc now owns 6,100 shares of the company’s stock worth $34,000 after purchasing an additional 2,900 shares during the last quarter. Great West Life Assurance Co. Can bought a new stake in shares of Viewray in the fourth quarter worth about $45,000. Finally, Citigroup Inc. grew its stake in shares of Viewray by 146.5% in the fourth quarter. Citigroup Inc. now owns 8,121 shares of the company’s stock worth $49,000 after purchasing an additional 4,826 shares during the last quarter.

VRAY has been the topic of several recent analyst reports. BidaskClub raised Viewray from a “hold” rating to a “buy” rating in a research note on Tuesday, January 22nd. ValuEngine raised Viewray from a “hold” rating to a “buy” rating in a research report on Wednesday, January 16th. Guggenheim started coverage on Viewray in a research report on Tuesday, January 15th. They set a “buy” rating and a $13.00 price objective on the stock. B. Riley reaffirmed a “buy” rating and set a $12.00 price objective (down from $13.75) on shares of Viewray in a research report on Monday, March 11th. Finally, Zacks Investment Research raised Viewray from a “hold” rating to a “buy” rating and set a $8.25 price objective on the stock in a research report on Saturday, February 9th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and nine have issued a buy rating to the company’s stock. Viewray has a consensus rating of “Buy” and a consensus target price of $12.63.

Shares of VRAY traded down $0.20 during mid-day trading on Wednesday, reaching $7.02. The company had a trading volume of 764,705 shares, compared to its average volume of 1,267,670. The company has a quick ratio of 4.24, a current ratio of 5.15 and a debt-to-equity ratio of 0.33. Viewray Inc has a 52 week low of $4.86 and a 52 week high of $13.21. The stock has a market cap of $694.09 million, a P/E ratio of -7.16 and a beta of 1.27.

Viewray (NASDAQ:VRAY) last issued its quarterly earnings results on Thursday, March 14th. The company reported ($0.17) EPS for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.06. Viewray had a negative return on equity of 58.78% and a negative net margin of 94.36%. The firm had revenue of $20.66 million for the quarter, compared to analysts’ expectations of $20.38 million. During the same period in the previous year, the firm posted ($0.38) EPS. The business’s revenue for the quarter was up 3.7% compared to the same quarter last year. On average, equities analysts anticipate that Viewray Inc will post -0.82 EPS for the current year.

TRADEMARK VIOLATION WARNING: “Millennium Management LLC Trims Stake in Viewray Inc (VRAY)” was first posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.baseballdailydigest.com/news/2019/04/24/millennium-management-llc-has-21-08-million-holdings-in-viewray-inc-vray.html.

Viewray Profile

ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.

Recommended Story: Purposes and Functions of the Federal Reserve

Institutional Ownership by Quarter for Viewray (NASDAQ:VRAY)

Receive News & Ratings for Viewray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viewray and related companies with MarketBeat.com's FREE daily email newsletter.